These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1089399)

  • 21. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ
    Commun Psychopharmacol; 1980; 4(5):441-5. PubMed ID: 7333096
    [No Abstract]   [Full Text] [Related]  

  • 24. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness.
    Coppen A; Rama Rao VA; Ruthven CR; Goodwin BL; Sandler M
    Psychopharmacology (Berl); 1979 Jun; 64(1):95-7. PubMed ID: 113840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does 24-h urinary MHPG predict treatment response to antidepressants? II. Association between imipramine response and low MHPG.
    Garvey M; DeRubeis RJ; Hollon SD; Evans MD; Tuason VB
    J Affect Disord; 1990 Nov; 20(3):181-4. PubMed ID: 2148338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noradrenergic output and clinical response in depressed women during amitriptyline therapy.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Pharmacopsychiatry; 1989 Jul; 22(4):144-51. PubMed ID: 2762377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal variation of urinary MHPG in unipolar and bipolar depressives.
    Giedke H; Gaertner HJ; Mahal A
    Acta Psychiatr Scand; 1982 Sep; 66(3):243-53. PubMed ID: 6127880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure to correlate urinary MHPG with clinical response to amitriptyline.
    Puzynski S; Rode A; Bidzinski A; Mrozek S; Zaluska M
    Acta Psychiatr Scand; 1984 Feb; 69(2):117-20. PubMed ID: 6702474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response.
    Beckmann H; Murphy DL
    Neuropsychobiology; 1977; 3(1):49-55. PubMed ID: 895998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of tricyclic antidepressant response: a critical review.
    Bielski RJ; Friedel RO
    Arch Gen Psychiatry; 1976 Dec; 33(12):1479-89. PubMed ID: 793564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary MHPG in subgroups of depressed patients and normal controls.
    Beckmann H; Goodwin FK
    Neuropsychobiology; 1980; 6(2):91-100. PubMed ID: 7354911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary MHPG levels and tricyclic antidepressant drug selection. A preliminary communication on improved drug selection in clinical practice.
    Cobbin DM; Requin-Blow B; Williams LR; Williams WO
    Arch Gen Psychiatry; 1979 Sep; 36(10):1111-5. PubMed ID: 475544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure to correlate urinary MHPG with clinical response to amitriptyline.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Psychopharmacol Bull; 1984; 20(1):171-3. PubMed ID: 6718644
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression.
    Loo H; Benkelfat C; Vanelle JM; Dennis T; Poirier MF; Olie JP; Scatton B
    J Neural Transm; 1986; 66(1):47-58. PubMed ID: 3734775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHPG excretion by patients with affective disorders.
    Maas JW; Dekirmenjian H; Fawcett JA
    Int Pharmacopsychiatry; 1974; 9(1):14-26. PubMed ID: 4600126
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary MHPG and response to amitriptyline.
    Modai I; Apter A; Golomb M; Wijsenbeek H
    Arch Gen Psychiatry; 1983 Apr; 40(4):467. PubMed ID: 6838327
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects.
    Muscettola G; Wehr T; Goodwin FK
    Am J Psychiatry; 1977 Aug; 134(8):914-6. PubMed ID: 879357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary 3-methoxy-4-hydroxyphenylglycol and psychiatric diagnosis.
    Taube SL; Kirstein LS; Sweeney DR; Heninger GR; Maas JW
    Am J Psychiatry; 1978 Jan; 135(1):78-82. PubMed ID: 618532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings].
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Cole JO; Rosenbaum AH
    Psychopharmacol Bull; 1981 Jan; 17(1):90-91. PubMed ID: 7232668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.